Sixteen states have taken Corteva and its seed and genetics spinoff, Vylor, to court over what they describe as an illegal transfer of billions of dollars in assets designed to strand PFAS-related liabilities tied to Corteva's corporate predecessor, DuPont.

The lawsuit, filed in Marion County, Indiana state court, names both Corteva — the agriscience giant formed in 2019 through the merger of DowDuPont's agriculture division — and Vylor, the newly separated seed and genetics business. According to the complaint, Corteva moved billions of dollars in assets to Vylor while leaving behind potential liabilities connected to per- and polyfluoroalkyl substances, the persistent chemicals known as PFAS that have generated sweeping litigation across the U.S. chemical and manufacturing sectors.

At the core of the case is the corporate lineage the states are challenging. Corteva was created in 2019 through a merger that separated DuPont's agricultural operations into a standalone company. The states contend that the more recent spinoff of Vylor continued that pattern of structural reorganization, shifting valuable seed and genetics assets beyond the reach of claimants while concentrating legacy PFAS exposure in entities with fewer resources to pay it.

For the agricultural sector, the litigation cuts close to the supply chain. Vylor holds the seed and genetics portfolio that growers know through Corteva's Pioneer and related trait and germplasm lines. The states' allegations, if they advance, could raise questions about how corporate restructuring within major input makers affects the legal and financial footing behind the seed genetics, traits and crop protection products farmers depend on each season.

The complaint characterizes the asset movement as a fraudulent transfer — a claim Corteva and Vylor will now have the opportunity to contest in Marion County court. Neither the docket's timeline nor the states' specific damage demands were detailed in the initial filing reports, and the companies had not publicly outlined their defense strategy in the immediate aftermath of the suit's disclosure.

PFAS liability has become one of the largest unresolved financial questions hanging over companies with roots in the mid-20th-century chemical industry. DuPont's history with fluorinated compounds has already produced multibillion-dollar settlement frameworks in other litigation, and the sixteen states now argue that Corteva's spinoff structure could limit recovery for cleanup costs, natural resource damages and other claims that taxpayers may otherwise absorb.

The legal question the Marion County court will eventually confront is whether the separation of Vylor was a legitimate business reorganization or a transfer engineered to defeat creditors and claimants. That distinction will turn on corporate records, valuation analyses and the sequencing of the asset movements — material that has not yet entered the public record.

For growers and ag retailers, the immediate commercial implications remain limited: the suit targets corporate structure, not product availability. But the outcome will shape the balance sheet standing behind a major seed and genetics franchise, and observers expect pretrial maneuvering over venue, standing and the admissibility of the states' transfer analysis to define the case's pace in the months ahead.